Just a reminder that anyone with CKD should automatically be assumed to already have clinically manifested atherosclerotic disease
The peptides include BPC-157, KPV, TB-500 and MOTs-C, each with intended medical uses for ulcerative colitis
Liraglutide stands out for having the strongest direct evidence of platelet inhibition, the controlled study showing 54% reduction in thromboxane-induced aggregation
How can I make tirzepatide work better
Immunol Lett
A peptide credited with somnogenic, analgesic, anti-stress, endocrine, and anti-withdrawal actions, with no receptor and no established pathway linking any of them, is a peptide whose reported activity has never been localized